EMJ GOLD: Pharma news, views and analysis S12 E01: The 2026 pharma forecast: Opportunities and threats
Feb 17, 2026
Leaders discuss treating health as growth infrastructure to boost innovation and access in Europe. They explore AI-driven personalization in scientific communications. The conversation highlights scaling women's health research and solutions. Risks covered include underinvestment, access delays, AI-generated misinformation, and workforce shortages.
AI Snips
Chapters
Transcript
Episode notes
Healthcare As Growth Infrastructure
- Europe can reframe healthcare as growth infrastructure rather than just cost to improve access to innovative medicines.
- Emma Charles argues investment in health strengthens outcomes, system resilience, and competitiveness across European markets.
Personalised Scientific Communications
- Personalisation in scientific communications is now achievable using AI, data, and technology to create dynamic, adaptive content.
- Dheepa Chari highlights translating insights and evidence into tailored content that can directly impact patient care.
Scaling Women's Health Priorities
- Closing the gap between women's health and men's health is a major opportunity to make women's health a core pillar of healthcare.
- Mary Stutts notes women's health has been underfunded despite women being a majority of workforce and patients, so scaling solutions can improve equity.